What is 475830.KQ's current stock price?

475830.KQ (Orum Therapeutics, Inc.) is currently trading at ₩61,900.00 with a market cap of ₩1.34T.

What sector is Orum Therapeutics, Inc. in?

Orum Therapeutics, Inc. (475830.KQ) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

475830.KQ Orum Therapeutics, Inc.

KOEHealthcare

₩61,900+5.81%LatestMarket Cap: ₩1.34T

As of 2026-08-09 03:15

Why 475830.KQ matters now

Orum Therapeutics, Inc. (475830.KQ) is a Korea stock in Healthcare. The latest InvestLog snapshot shows ₩61,900.00 with +5.81% on the session and ₩1.34T in market capitalization.

Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E -91.28, gross margin -5659393.5%, and operating margin -123201358.1%.

Valuation

P/E (TTM)

-91.28

PEG

—

P/B

11.68

P/S

89439658.22

EV/EBITDA

-71.08

DCF Value

—

FCF Yield

-3.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

-5659393.5%

Operating Margin

-123201358.1%

Net Margin

-104129439.0%

ROE

-22.1%

ROA

-4.9%

ROIC

-12.4%

Listing Info

Market

Korea

Exchange

KOE

Currency

KRW

Sector

Healthcare

Industry

Biotechnology

Country

Orum Therapeutics, Inc. is a biopharmaceutical company dedicated to the discovery and development of novel therapeutic solutions for both cancer and immune system conditions. The firm specializes in creating degrader-antibody conjugates, an innovative class of drugs that merges traditional antibody-drug conjugate (ADC) technology with targeted protein degradation. Their flagship product candidate, ORM-1153, functions as a GSPT1 protein degrader, specifically engineered to address hematologic malignancies. Orum Therapeutics was established in 2016 and operates out of Daejeon, South Korea.